Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

199.77 +8.52 (+4.45%)

Streaming Delayed Price Updated: 9:46 AM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday? ↗

July 23, 2024

Tuesday's Wall Street session was mixed, with small-caps outperforming large-caps as investors awaited earnings from Alphabet Inc. and Tesla Inc.

Via Benzinga

DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q2 2024 ↗

July 23, 2024

DGX stock results show that Quest Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist ↗

July 23, 2024

The market mood turned jittery after Monday’s rebound, with index futures trading on either side of the unchanged line early Tuesday. The apprehensions reflect uncertainties regarding geopolitics,...

Via Benzinga

Topics Artificial Intelligence

Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗

July 21, 2024

The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season.

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics ↗

July 05, 2024

Via Benzinga

How Is The Market Feeling About Quest Diagnostics? ↗

June 27, 2024

Via Benzinga

Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy

July 18, 2024

From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology

Via GlobeNewswire

EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy ↗

July 18, 2024

Haystack Oncology, a Quest Diagnostics company, and Lisata Therapeutics collaborate to use Haystack MRD technology in a study of certepetide plus chemotherapy for metastatic pancreatic cancer, focusing...

Via Benzinga

S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 05, 2024

Via Benzinga

Topics Stocks

Peering Into Quest Diagnostics's Recent Short Interest ↗

June 10, 2024

Via Benzinga

Analyst Scoreboard: 7 Ratings For Quest Diagnostics ↗

May 30, 2024

Via Benzinga

How Is The Market Feeling About Quest Diagnostics? ↗

May 24, 2024

Via Benzinga

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests

June 18, 2024

Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including

Via MarketBeat

Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High ↗

May 15, 2024

Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered samples out of 5.5 million in 2023. The rise in synthetic urine use and...

Via Benzinga

Topics Cannabis

Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX

April 30, 2024

Via AB Newswire

Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth ↗

April 25, 2024

Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.

Via Talk Markets

Peering Into Quest Diagnostics's Recent Short Interest ↗

April 24, 2024

Via Benzinga

The Analyst Landscape: 5 Takes On Quest Diagnostics ↗

April 24, 2024

Via Benzinga

Balancing Dividends and Fundamentals: The Case of NYSE:DGX. ↗

April 10, 2024

Uncovering Dividend Opportunities with QUEST DIAGNOSTICS INC (NYSE:DGX).

Via Chartmill

Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic ↗

April 23, 2024

Latest financial insights from Quest Diagnostics. Q1 results beat estimates with adjusted EPS of $2.04 and sales of $2.34 billion, showcasing nearly 6% base business revenue growth.

Via Benzinga

DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q1 2024 ↗

April 23, 2024

DGX stock results show that Quest Diagnostics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory' ↗

April 22, 2024

Wall Street appears to be shrugging off rate worries as major stock index futures were moderately higher in early pre-market trading on Monday in the hopes of getting some respite from Big Tech...

Via Benzinga

Why NYSE:DGX provides a good dividend, while having solid fundamentals. ↗

March 19, 2024

Balancing Dividends and Fundamentals: The Case of QUEST DIAGNOSTICS INC (NYSE:DGX).

Via Chartmill

(DGX) - Analyzing Quest Diagnostics's Short Interest ↗

March 05, 2024

Via Benzinga

Earnings Scheduled For April 23, 2024 ↗

April 23, 2024

Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion.

Via Benzinga

Key Takeaways From Quest Diagnostics Analyst Ratings ↗

March 20, 2024

Via Benzinga

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week ↗

April 21, 2024

Corporate profit growth rose in Q3 2023 and is expected to continue in Q1.

Via Benzinga

LifeMD Shares Come Back to Life on GLP-1 Business Growth

March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024

Via MarketBeat

AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow ↗

March 18, 2024

Benzinga used Public.com's bond screener tool to identify some of the highest-yielding investment-grade corporate bonds.

Via Benzinga

Topics Bonds

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.